AAV-miniCMV-SpCas9 (AAV Serotype 9)

Product Category: Pre-made recombinant AAV | AAV-miniCMV-Cas9 | AAV9-miniCMV-SpCas9 | AAV-Cas9 | AAV9-SpCas9
Description:
AAV9-miniCMV-SpCas9 is a pre-packaged recombinant AAV vector based on serotype 9 (AAV9 capsid with AAV2 ITRs), designed for efficient delivery and expression of a human codon-optimized Streptococcus pyogenes Cas9 (SpCas9) nuclease. Expression is driven by the compact miniCMV promoter, enabling robust Cas9 expression while maintaining a minimized cassette size suitable for AAV packaging constraints.
This vector is optimized for in vivo genome editing applications, particularly in tissues with high AAV9 tropism such as the central nervous system, heart, and muscle. Supplied in a ready-to-use format, it is suitable for both in vitro and in vivo CRISPR-mediated gene editing studies.
Titer: >1E+13 VG/mL
Size: 30 µL (Std Pack)
Reconstitution Buffer: Sterile PBS supplemented with final 0.005% Pluronic F-68 and 200 mM NaCl
CITATIONS
| Shipping Weight | 6 lbs |
|---|---|
| Unit Size | 30 µL at >10¹³ VG/mL, 10 µL at >10¹³ VG/mL |
Customers who bought this product also purchased…
-
SL100832AAV-Null (AAV Serotype 8)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
Custom Service Solutions
Looking for a customized solution? Our end-to-end capabilities support both in vitro and in vivo applications, with rigorous quality control, scalable production processes, and expert scientific oversight at every stage.

